Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol for Hemodynamic Effects in Septic Shock
NCT02369900Phase 2Terminated
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Mar 2015
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of esmolol in septic shock, sponsored by Beth Israel Deaconess Medical Center. Started Mar 2015; status: terminated.
02
Drugs
esmolol
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02369900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369900.